WO2003077827A1 - Procede de production de medicament solide en dispersion - Google Patents

Procede de production de medicament solide en dispersion Download PDF

Info

Publication number
WO2003077827A1
WO2003077827A1 PCT/JP2003/003226 JP0303226W WO03077827A1 WO 2003077827 A1 WO2003077827 A1 WO 2003077827A1 JP 0303226 W JP0303226 W JP 0303226W WO 03077827 A1 WO03077827 A1 WO 03077827A1
Authority
WO
WIPO (PCT)
Prior art keywords
kneading
disk
kneaded
rotating shaft
supply
Prior art date
Application number
PCT/JP2003/003226
Other languages
English (en)
Japanese (ja)
Inventor
Tomio Nakano
Shogo Izumi
Original Assignee
Nippon Shinyaku Co., Ltd.
Imoto Machinery Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co., Ltd., Imoto Machinery Co., Ltd. filed Critical Nippon Shinyaku Co., Ltd.
Priority to JP2003575881A priority Critical patent/JPWO2003077827A1/ja
Publication of WO2003077827A1 publication Critical patent/WO2003077827A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/0002—Processes of manufacture not relating to composition and compounding ingredients
    • A23G3/0004—Processes specially adapted for manufacture or treatment of sweetmeats or confectionery
    • A23G3/0006—Manufacture or treatment of liquids, pastes, creams, granules, shred or powder
    • A23G3/0017—Transformation of a liquid, paste, cream, lump, powder, granule or shred into powder, granule or shred; Manufacture or treatment of powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/04—Particle-shaped
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/36—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
    • B29C48/375—Plasticisers, homogenisers or feeders comprising two or more stages
    • B29C48/38—Plasticisers, homogenisers or feeders comprising two or more stages using two or more serially arranged screws in the same barrel
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/36—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
    • B29C48/475—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using pistons, accumulators or press rams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/20—Extrusion means, e.g. for producing pharmaceutical forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Definitions

  • the present invention relates to a method for producing a solid pharmaceutical dispersion useful as a raw material for a pharmaceutical preparation.
  • Solid dispersions can be analyzed by X-ray diffractometry, as can be seen from the disappearance of the crystal peak of the drug in the inert carrier, as the drug is dissolved or in the solid state in the solid inert carrier. It can be said that it is dispersed in a monomolecular form, and is distinguished from a simple mixture or a physical mixture in which an inert carrier and a drug are present independently (eg, G3 ⁇ 4em. Pharm. Bull. , 30, 4479 (1982)).
  • an inert carrier is sufficiently used for the drug, it can be considered that the drug is largely amorphous in the carrier.
  • the usefulness of a solid pharmaceutical dispersion is that it can improve the solubility of a poorly water-soluble drug in a living body and enhance its bioavailability.
  • solid pharmaceutical dispersions are prepared by dissolving a solid inert carrier and a drug in an appropriate solvent, and then distilling off the solvent. Then, it can be produced by a melting method by cooling and a solvent-melting method which is an eclectic method. It can also be manufactured by a mixing and pulverization method in which a solid inert carrier and a drug are mixed and pulverized vigorously. Recently, a twin-screw compound extruder with a special screw element called a kneading paddle has been developed. Production methods such as a kneading extrusion method (eg, WO92 / 18106) are also known.
  • a kneading extrusion method eg, WO92 / 18106
  • the material to be kneaded is compressed and sheared by the rotation of a disk and spirally transferred by the rotation of a spiral screw to produce a kneaded material.
  • a rotating disk is fixed at the center to the rotating shaft with a screw around the outer periphery so that the screw is transferred, and peaks and valleys are alternately radially formed on at least one surface of this rotating disk. Formed and opposed to this surface
  • a fixed disk is fixed to the cylinder coaxially and arranged so that a gap is formed between the fixed disk and the rotary shaft, and peaks and valleys are alternately radially formed on the surface of the fixed disk with respect to the rotary disk.
  • the kneading extruder (hereinafter referred to as “the main kneading extruder”) configured to be fed out is a machine for producing kneaded materials of plastic (polymer) material and other various materials. It can be considered as an extension of the principle of grinding raw materials with a mill.
  • Such a kneading extruder is also referred to as a continuous kneader, a kneading extruder, a continuous kneading extruder, and the like (for example, a kneading extruder described in JP-A-8-183027).
  • An object of the present invention is to provide a novel method for producing a solid pharmaceutical dispersion.
  • a new method of using the kneading extruder is provided. This effort can include, for example:
  • a method for producing a solid pharmaceutical dispersion comprising at least a pharmaceutically acceptable polymer carrier and a pharmaceutical by the kneading extruder.
  • the material supply unit for feeding the material to be kneaded and the material to be kneaded sent from the material supply unit are compressed and sheared by rotation of a disk having a shallow groove on the peripheral surface, and are spirally transferred by rotation of the spiral screw.
  • the material kneading unit 4 is positioned laterally around the spiral screw 6a and the material kneading unit 4 is positioned on the material supply unit 2 side and fed from the material supply unit 2.
  • the disk 3 having a diameter larger than the rotation shaft 6 fixed coaxially with the rotation shaft 6 for transferring the material to be kneaded to the rotation shaft 6 while compressing / shearing and kneading the mixture;
  • a cylindrical horizontal hole opening 8 formed in a size that can be rotated with the plate 3 provided inside is provided at the rear end portion 10b, and a cylindrical shape large enough to rotate with the rotation shaft 6 provided inside.
  • the movable portion 19 is reciprocated to move between the rotation shaft side surface of the disk 3 and the bottom surface 8a of the cylindrical lateral hole opening 8.
  • the degree of compression and shearing according to the type of the material to be kneaded can be obtained by adjusting the gap formed in the kneaded material.
  • the material supply section for feeding the material to be kneaded and the material to be kneaded fed from the material supply section are compressed and sheared by rotation of a disk having a shallow groove on the peripheral surface, and are spirally transferred by rotation of the spiral screw.
  • the material kneading unit 4 is positioned laterally around the spiral screw 6a and the material kneading unit 4 is positioned on the material supply unit 2 side and fed from the material supply unit 2.
  • the disk 3 having a diameter larger than the rotation shaft 6 fixed coaxially with the rotation shaft 6 for transferring the material to be kneaded to the rotation shaft 6 while compressing / shearing and kneading the mixture;
  • a cylindrical lateral hole opening 8 formed in a width that allows the plate 3 to be installed and rotatable is provided at the rear end 10b, and a cylindrical lateral hole 9 that is large enough to be rotatable with the rotary shaft 6 installed is a circle.
  • Kneading-side cylinder portion formed from bottom surface 8a of column-shaped lateral hole opening 8 to tip end surface 10c
  • a supply-side cylinder portion 13 having a distal end portion 13a having a shape in which the material supply portion 2 is reciprocally fitted into the cylindrical lateral hole opening portion 8 and the distal end portion 13a is opened;
  • a kneading extruder 1 comprising a piston part 14 for extruding the material to be kneaded introduced into the supply-side cylinder part 13 to a tip part 13a, wherein the kneading-side cylinder part 10 is in the longitudinal direction of the rotary shaft 6.
  • the supply-side cylinder portion 13 is fixed to a supply-side movable portion 20 that reciprocates in the same direction as the longitudinal direction of the rotary shaft 6 and is kneaded.
  • the movable section 19 is reciprocated to adjust the kneading-side gap formed between the rotation shaft side surface of the disk 3 and the bottom surface 8a of the cylindrical lateral hole opening 8, and to reciprocate the supply side movable section 20.
  • a material having a degree of compression and shearing according to the type of the material to be kneaded can be obtained.
  • the material supply section for feeding the material to be kneaded and the material to be kneaded fed from the material supply section are compressed and sheared by rotation of a disk having a shallow groove on the peripheral surface, and are spirally transferred by rotation of the spiral screw.
  • the material kneading unit 4 is positioned side by side with the rotating shaft 6 around the spiral screw 6a and the material kneading unit 4 is fed from the material supply unit 2.
  • the disk 3 is coaxially fixed to the rotating shaft 6 and has a diameter larger than that of the rotating shaft 6 for transferring the material to be kneaded to the rotating shaft 6 while compressing and shearing the kneaded material;
  • a cylindrical lateral hole opening 8 formed in the rear end portion 10b is formed in a rear end portion 10b so as to be rotatable with the disk 3 installed therein. Is formed from the bottom surface 8a of the cylindrical lateral hole opening 8 to the tip end surface 10c.
  • a supply-side cylinder portion 13 having a distal end portion 13a having a shape in which the material supply portion 2 is reciprocally fitted into the cylindrical lateral hole opening portion 8 and the distal end portion 13a is opened; It is rotatably provided in the supply-side cylinder portion .13 and is fixed to the disk 3 coaxially with the rotary shaft 6 and the material to be kneaded introduced into the supply-side cylinder portion 13 is rotated to the tip portion 13a.
  • a kneading extruder 1 comprising a transfer screw shaft 36 to be extruded, wherein the kneading-side cylinder portion 10 is fixed to a kneading-side movable portion 19 that reciprocates in the same direction as the longitudinal direction of the rotary shaft 6 and kneaded.
  • the kneading material is adjusted by reciprocating the side movable portion 19 to adjust the kneading-side gap formed between the rotation shaft side surface of the disk 3 and the bottom surface 8a of the cylindrical lateral hole opening 8.
  • FIG. 1 is a side view showing a kneading extruder according to the present kneading extruder
  • FIG. 2 is a plan view of the kneading extruder shown in FIG. 1.
  • FIG. 1 the supply-side movable plate and the kneading side shown in FIG. The movable plate is omitted, and the supply-side cylinder portion and the kneading-side cylinder portion are illustrated in cross sections in FIGS. 1 and 2.
  • FIG. 3 is an explanatory view of the kneading-side cylinder portion shown in FIG. 1.
  • FIG. FIG. 3 (b) is a left side view of the kneading side cylinder section
  • FIG. 4 is an explanatory view of the disk shown in FIG. 1.
  • FIG. 4 (a) is a front view of the disk
  • FIG. 4 (b) is a right side view of the disk
  • FIG. ) Is a left side view of the disk
  • FIG. 4 (d) is a vertical sectional view taken along line AA of the disk shown in FIG. 4 (c).
  • FIG. 5 is a longitudinal sectional view illustrating a movable mechanism for reciprocating the supply-side movable plate and the kneading-side movable plate illustrated in FIG.
  • reference numeral 1 denotes a spiral which compresses and shears the material to be kneaded, which is fed from the material supply unit 2, and the disk 3, which has a shallow groove on its peripheral surface, by rotating it.
  • a material kneading unit 4 that spirally transfers by rotation of the screw is a patch-type kneading extruder that is horizontally arranged on a gantry 5 in series.
  • the material kneading unit 4 compresses and kneads the kneaded material, which is positioned on the side of the material supply unit 2 and is fed from the material supply unit 2, by shearing and kneading the rotating shaft 6 around which the spiral screw 6 a is provided.
  • the disk 3 having a diameter larger than that of the rotary shaft 6 fixed coaxially to the rotary shaft 6 for transferring to the rotary shaft 6 side, and a discharge port 7 for discharging the kneaded material to be kneaded are provided at the tip end.
  • a cylindrical horizontal hole opening 8 is provided at the rear end 10b, and is provided on the 10a side, and is formed to have a size that allows the disk 3 to be installed and rotated.
  • a kneading side cylinder portion 10 formed from a bottom surface 8a of the cylindrical side hole opening 8 to an end surface 10c of the tip end portion 10a.
  • the cylindrical side hole opening 8 has a width. As shown in Fig. 3, the bottom surface 8a of the cylindrical lateral hole opening 8 As such, radial shallow bottom groove 8b running include openings of the tubular lateral hole 9 is formed.
  • the disk 3 is provided with a hexagonal shaft hole 3a at the center thereof, into which the rear end 6b (see FIG. 1) of the rotary shaft 6 is fitted and axially attached.
  • a plurality of fan-shaped shallow grooves 3b are formed radially extending from the vicinity of the hexagonal shaft hole 3a of the disk 3, and the circumferential surface of the disk 3 is
  • a plurality of gutter-shaped shallow-bottom grooves 3c are formed at intervals so as to cross the fan-shaped shallow-bottom grooves 3b obliquely.
  • the rotating shaft 6 has a distal end connected to a motor (not shown) and a connecting shaft having a diameter that can be rotatably provided in the cylindrical hole 9.
  • a screw-type screw that fits on the tip end 10a side of the kneading-side cylinder part 10 around which a screw-type spiral screw 6e that continues through a circular constriction 6d having a width that fits in the diameter of the discharge port 7 is provided.
  • the circumferential surface of the screw-type rotary shaft portion 6f has a narrow groove 6h having a length that does not reach both ends of the screw-type rotary shaft portion 6f in parallel with the longitudinal direction of the rotary shaft 6. 2) is formed, and the narrow groove eh running halfway from both ends and the narrow groove 6h formed in ⁇ on the circumferential surface are spaced apart. And is provided so as not to overlap with (a contact, in FIG. 2, the screw-type spiral disk. Liu 6e is omitted.).
  • the connecting rotary shaft 6c of the rotary shaft 6 is passed through a bearing 12 provided in the fixed angle portion 11 on the kneading section side erected on the gantry 5, and the distal end of the connecting rotary shaft 6c is connected to the motor via a coupling or the like.
  • the orbiting portion 6d of the rotating shaft 6 is located at the discharge port 7, and the screw-type rotating shaft 6f around which the spiral screw of the rotating shaft 6 is provided and the screw rotating shaft 6g are cylindrical.
  • the disk 3, which is provided in the lateral hole 9 and fitted to the rear end 6 b of the rotary shaft 6, is provided in the column-shaped lateral hole opening 8.
  • the material supply unit 2 has a tip 13a formed in a circular shape that reciprocally fits into the cylindrical lateral hole opening 8.From the tip 13a, the rotation shaft 6 is rotated around the rotation shaft 6.
  • a supply-side cylinder portion 13 provided with a horizontal hole-shaped cavity portion 13b for sending out the material to be kneaded formed in the same direction as the longitudinal direction and opening at both ends, and the material to be kneaded charged into the supply-side cylinder portion 13 are provided.
  • An opening 13c for charging the material to be kneaded is formed in the rear upper wall of the supply-side cylinder 13 and is formed in the opening 13c.
  • the piston portion 14 is provided with a pushing handle shaft 16 having a thread groove formed on a circumferential surface of the piston portion 14, and the handle shaft 16 is fixed to a supply portion standing upright on the base .5. Angle The hand screw (not shown) is screwed into the slot 17a and fixed to the rear end thereof.
  • two column shafts 18, 18 sandwiching a kneading-side cylinder portion 10 and a supply-side cylinder portion 13, which are connected in series and are arranged side by side, are connected to the longitudinal axis of the rotating shaft 6.
  • the kneading part side fixed angle 11 and the supply part side fixed angle 17 are installed in parallel with the direction, and the kneading side movable plates (kneading side movable part) 19, 19 and the supply side movable
  • One end of each of the plates (supply-side movable parts) 20 and 20 is reciprocally mounted, and the other ends of the kneading-side movable plates 19 and 19 are provided on both sides of the kneading-side cylinder unit 10 via heat insulating plates 21 from both sides.
  • the supply 3 ⁇ 4lj movable plates 20, 20 are fixed to the rear end portion 10b of the supply side cylinder portion 13 on both sides of the supply side cylinder portion 13 via heat insulating plates 21 from both sides. Is fixed to the flange 13d with a port '(not shown) or the like.
  • Supply-side movable mechanisms 23 and 23 for reciprocating the supply cylinder 22 and the supply-side cylinder 13 in the same direction as the longitudinal direction of the rotating shaft 6 are provided.
  • reference numeral 24 denotes a bearing provided on the end face 10c of the kneading cylinder part 10
  • reference numeral 25 denotes a leakage of the kneaded matter fitted between the end face 10c of the kneading cylinder part 10 and the bearing 24.
  • the stop ring 26 is a ring for preventing the material to be kneaded from being sheared, which is fitted to the end face of the rear end portion 10b of the kneading side cylinder portion 10.
  • a heater is attached to the kneading cylinder 10 and the supply cylinder 13 so that the temperature can be adjusted.
  • the kneading-side movable mechanisms 22, 22 and the supply-side movable mechanisms 23, 23 are symmetrically arranged and have the same configuration
  • the kneading-side movable mechanism 22 arranged on the upper side in FIG. 2 is taken as an example.
  • the configuration of the movable mechanisms 22 and 23 will be described. As shown in FIG.
  • the kneading-side movable mechanism 22 includes a spacer 27 that reciprocates from the left side of the kneading-side movable plate 19 to the column shaft 18 and contacts the kneading-side movable plate 19, Disk 3 is inserted into cylindrical side hole opening 8 of kneading cylinder 10
  • a hexagonal nut 28 screwed into a thread groove '18a on the peripheral surface of the support shaft 18 formed so as to be positioned on the left side of the kneading-side movable plate 19 in the accommodated state until it comes into contact with the spacer 27;
  • a gap adjusting screw portion 29 that reciprocates from the right side of the movable plate 19 to the column shaft 18 and abuts on the kneading-side movable plate 19 .
  • the gap adjusting screw portion 29 has a hexagonal head 30 a Represents the width of the kneading-side gap formed between the bolt-shaped
  • a knob 31 is screwed onto the body 30c of the fixed part 30 and has a scale engraved on the circumferential surface.
  • the scale marked on the knob 31 of the supply-side movable mechanism 23 represents the width of the supply-side gap formed between the end face 13a of the supply-side cylinder 13 and the side surface of the disk 3.
  • Reference numeral 32 denotes a female screw hole for a set screw formed in the hexagonal head 30a.
  • the fixing part 30 is fixed to the support shaft 18 by screwing a set screw 33 into the female screw hole 32 until the support shaft 18 is reached. .
  • the hex nuts 28 and the set screws 33 of the kneading-side movable mechanisms 22, 22 are loosened so that the bottom 8a of the cylindrical side hole opening 8 contacts the side surface of the disk 3 on the kneading side.
  • the kneading cylinder 10 is moved in the direction of arrow X by reciprocating the movable plates 19, 19, and the set screw 33 is tightened while the bottom surface 8a of the cylindrical side hole opening 8 is in contact with the side surface of the disk 3. Fix the fixing part 30 to the support shafts 18 and 18 with.
  • the knob 31 is turned to move the kneading-side movable plates 19, 19 in the arrow Y direction (arrow: in the direction opposite to the X direction) in order to obtain a gap width on the kneading side corresponding to the kind of material to be kneaded.
  • the hexagonal nut 28 is tightened with the desired kneading-side gap width formed, and the spacer 27 is pressed against the kneading-side movable plates 19, 19. Fix it.
  • the knob 31 is turned to move the movable plate 20 on the supply side in the direction of the arrow X (the direction opposite to the direction of the arrow Y) so as to obtain the above-mentioned gap on the supply side according to the type of the material to be kneaded.
  • the hexagon nut 28 is tightened in a state where the desired supply-side gap width is formed, and the spacer 27 is pressed against the supply-side movable plates 20 and 20 to fix the supply-side movable plates 20 and 20.
  • the handwheel is turned to transfer the material to be kneaded to the tip portion 13a of the supply-side cylinder portion 13 by turning the handwheel.
  • the material to be kneaded transferred to the distal end 13a is pressed by the supply side side surface of the rotating disk 3 in the supply side gap, and compressed by the shallow groove 3b formed on the side surface while melting by heating. Sheared.
  • the kneading-side cylinder portion 10 is fixed to the kneading-side movable plates 19, 19 which reciprocate in the same direction as the longitudinal direction of the rotating shaft 6, and the cylindrical horizontal hole orifice of the kneading-side cylinder portion 10 is fixed.
  • the supply-side movable plate 20, 20 which reciprocates the supply-side cylinder portion 13 in the same direction as the longitudinal direction of the rotary shaft 6 with the distal end portion 13a of the supply-side cylinder portion 13 inserted in the mouth portion 8 so as to be able to reciprocate.
  • the kneading-side movable plates 19, 19 are reciprocated by the kneading-side movable mechanisms 22, 22 to form the kneading formed between the rotation shaft side surface of the disk 3 and the bottom surface 8a of the cylindrical lateral hole opening 8.
  • the supply side movable plates 20, 20 are reciprocated by the supply side movable mechanisms 23, 23 so that the side surface of the disk 3 on the material supply side and the supply side cylinder 13 Since the supply-side gap formed between the tip 13a and the end face is adjusted, the compression * shearing degree can be obtained according to the type of the material to be kneaded, eliminating the need to provide a plurality of rotating disks.
  • the kneading degree can also be improved, so that the kneading-side cylinder portion 10 can be shortened.
  • the shallow grooves 3b and 3c formed on the peripheral surface of the disk 3 may have a valley shape formed by forming a projection on the peripheral surface. Further, the rotary shaft 6 may have a helical screw 6a provided around the orbital constriction 6d.
  • FIG. 6 is a plan view showing a kneading extruder according to the present embodiment, in which a supply-side cylinder portion and a kneading-side cylinder portion are illustrated in cross sections.
  • 7 is a longitudinal sectional view illustrating the bearing portion illustrated in FIG. 6, and
  • FIG. 8 is a longitudinal sectional view illustrating a movable mechanism that reciprocates the kneading-side movable plate illustrated in FIG.
  • the kneading extruder shown in FIG. 6 is a continuous kneading extruder, and the same reference numerals as those in FIGS. 1 to 5 indicate the same or corresponding parts.
  • a spiral screw 6a is provided around a rotating shaft 6 in a material kneading section 4.
  • the tip of the small screw 34 has a smaller diameter than the outer diameter of the spiral screw 6a (see FIG. 7), and the small screw 34 is fixed to the end face 10c of the kneading cylinder part 10.
  • Axle-mounted inside part 35 is provided inside part 35.
  • a transfer screw shaft 36 which is fixed to the disk 3 coaxially with the rotating shaft 6 and pushes the material to be kneaded introduced into the supply side cylinder section 13 to the tip 13a while rotating, is rotated.
  • the transfer screw shaft 36 is screwed with a screw screw shaft 37 for feeding the material to be kneaded into the transfer screw shaft 36.
  • What is screw screw shaft 37 It is connected to a gear box 38 via a supply-side fixed angle portion 17, and is connected to a motor shaft 40 via a gear system 39 in the gear box 38.
  • the kneading-side cylinder unit 10 is fixed to kneading-side movable plates 19, 19 and is reciprocally attached to the support shafts 18, 18 via kneading-side movable mechanisms 22, 22.
  • the distal end 13a of the supply-side cylinder portion 13 is reciprocally inserted into the cylindrical side hole opening 8 of the kneading-side cylinder portion 10 with the supply-side gap provided, and the material is kneaded with the material supply portion 2.
  • Part 4 is laid horizontally.
  • the bearing portion 36 has a guide groove 41a formed in the middle of the circumferential surface in parallel with the longitudinal direction of the rotating shaft 6 and a hole opening from the end of the guide groove 41a toward the end face.
  • a groove 41b is formed, and a kneaded material forming ring 41 is fixed to the small shaft portion 34 of the rotating shaft 6 with a gap between the spiral screw 6a, and a guide ring 41 is fixed to the small shaft portion 34.
  • a cylindrical shaft-mounting opening 42a having a size capable of rotating and reciprocating internally in the state, and a discharge port 7 having a bottom formed in a mortar shape and opening toward the tip are formed. It is composed of a provided screw thread receiving portion 42 and a lotus root type breaker plate 43 having a myriad of holes that closes a mortar-shaped bottom surface and is fitted into a cylindrical shaft mounting opening portion 42a.
  • the kneading-side movable mechanisms 22 and 22 are located on the left side from the position including the kneading-side movable plate 19 in a state where the disk 3 is accommodated in the cylindrical lateral hole opening 8 of the kneading-side cylinder unit 10.
  • a hexagon nut 28 screwed into a screw groove 18a formed to the end surface of the support shaft 18 and a fitting formed on the kneading-side movable plate 19 by reciprocatingly passing through the support shaft 18 from the right side with respect to the kneading-side movable plate 19. It comprises a cylindrical slider 45 having an outer peripheral surface 45a fitted in the mating hole 44 and a gap adjusting screw portion 29 abutting on the cylindrical slider 45.
  • Reference numeral 46 denotes a heater
  • 47 denotes a fixing ring for fixing the leak preventing ring 26
  • 48 denotes a port to which the fixing angle section 17 on the supply section side is fixed to a stand 5J.
  • the knob 31 is turned to move the kneading-side movable plates 19, 19 in the direction of the arrow Y (in the direction of the arrow X) in order to obtain the above-mentioned kneading-side gap width according to the type of the material to be kneaded. In the opposite direction) and tighten the hexagon nut 28 with the desired kneading-side gap width formed to fix the kneading-side movable plates 19, 19.
  • the guide ring 41 fixed to the small shaft portion 34 of the rotary shaft 6 is moved by reciprocating the kneading-side movable plates 19, 19 in the directions of arrows X and Y, so that the shaft of the screw receiving portion 42 is rotated. It reciprocates in the receiving opening 42a. .
  • the transfer screw shaft 36 and the mating screw shaft 37 that are rotating inward to each other. It is transferred to the tip 13a of the supply-side cylinder unit 13.
  • the material to be kneaded transferred to the leading end 13a is pressed by the supply side side surface of the rotating disk 3 in the supply side gap, and melts by heating to form the shallow bottom groove 3b formed on the side surface. Compressed and sheared.
  • the compressed and sheared material to be kneaded passes through the shallow groove 3c of the disk 3 and is further compressed and sheared with the side wall of the cylindrical lateral hole opening 8, the kneading side of the disk 3 is kneaded. It reaches the shallow groove 3b formed on the side surface and compresses and kneads with the radial shallow groove 8b formed on the bottom surface 8a of the cylindrical lateral hole opening 8 at the kneading-side gap.
  • the supply-side gap cannot be adjusted, but the kneading-side gap can be adjusted.
  • the rotating shaft 6 is connected to the kneading-side cylinder. It's stripped out of 10
  • the same effect as in the first embodiment can be obtained.
  • the transfer screw shaft 36 and the mating screw shaft 37 may rotate outward from each other, or the rotating shaft 6 may be formed of a two-axis screw. Further, the transfer screw shaft 36 may be transferred by a single screw without the joint screw shaft 37 being provided.
  • the polymer carrier that can be used in the present invention is not particularly limited, such as water-soluble or water-insoluble, as long as it is a pharmaceutically acceptable polymer carrier, but a pharmaceutically acceptable water-soluble polymer carrier is preferred.
  • the polymer carrier that can be used in the present invention include a cellulose derivative, a synthetic polymer compound, a natural polymer compound (polybranides) or a derivative thereof, and a starch derivative. Specific examples are shown below.
  • the term “water-soluble” refers to a property of dissolving in at least one water or aqueous solution such as distilled water, purified water, tap water, intestinal juice, gastric juice and the like.
  • HPMC 2208 Metalroze (registered trademark, same hereafter) 90 SH, SB-4), 2906 (Metroize 65 SH), 2910 (Metroze 60 SH, TC-5 (registered trademark, same hereafter) )
  • Etc. oleoxymethylcellulose (CMC), carboxymethylcellulose sodium (CMC-Na), hydroxypropylmethylcellulose acetate succinate (HPMCAS; eg, AQOAT® L, M, H) ), Hydroxypropyl methylcellulose phthalate (HPMCP; eg, HPM CP220824 (HP50), 220731 (HP55)), carboxymethylethylcellulose (CM EC), cellulose acetate phthalate (CAP) 0
  • Echinoresenorelose (EC). 2. Synthetic polymer compound
  • Polyvinylpyrrolidone (PVP; eg, Kollidone (registered trademark, the same applies hereinafter) K30, K60, K90), N-vinylpyrrolidone.Acetate copolymer (eg, Kollidone VA64), Polybutyl alcohol (PVA), canolepoxy vinyl polymer (polyacrylic acid; eg, Carbopol (registered trademark), Hibisco® (registered trademark)), polyethylene glycol (macrogol; eg, PEG400, 6000), polyethylene oxide ( PEO), methacrylic acid copolymer (eg, Eudragit (registered trademark, the same applies hereinafter) L30D-55, L100-55, L100, S100), aminoalkyl methacrylate copolymer (eg, Eudragit) E 100), polyvinyl acetate tilamino acetate (AEA).
  • PVD-55, L100-55, L100, S100 aminoal
  • Aminoalkyl methacrylate copolymer eg, Eudragit RS 30D, RS 100, RL 30D, RL 100.
  • Starch eg, potato starch, corn starch.
  • Dextrin eg, Amicol (registered trademark), matsunoline (registered trademark)), o cyclodextrin, 'cyclodextrin, ⁇ -cyclodextrin, sodium carboxymethylstarch (eg, Primodiel (registered trademark), Explotab (registered trademark)), Pullulan.
  • a-starch eg, Amicol (registered trademark), matsunoline (registered trademark)
  • o cyclodextrin eg, 'cyclodextrin
  • ⁇ -cyclodextrin sodium carboxymethylstarch
  • Primodiel registered trademark
  • Explotab registered trademark
  • the drug that can be used in the present invention is not particularly limited, but has a solubility of 500 ⁇ g / m1 or less in the first or second liquid of the 14th pharmacopeia at a temperature of 2.5 ° C.
  • a sparingly soluble drug is suitable, and a sparingly soluble drug having a solubility of 100 ⁇ g / m 1 or less in a first solution or a second solution of the Japanese Pharmacopoeia No. 14 at a temperature of 25 ° C. is preferable.
  • Specific examples include the following medicaments.
  • Sulpiride setraxa hydrochloride, gefarnato, inolesogladine maleate, cimetidine, laetidine hydrochloride, famotidine, dizatidine, xantidine acetate hydrochloride, sodium azulene sulfonate.
  • Peptide bromide patin sulphate, oxopodium bromide, timevidium bromide, butylscopolamine bromo, trospium chloride, butium pium bromide, N-methylscopolamine methyl sulphate, methyl octatropine bromide.
  • Chlorphenesin carpamic acid Tolperisone hydrochloride, Eperisone hydrochloride, Tiza-zine hydrochloride, Mefenecin, Chronorezoxazone, Fenprobamate, Metocarpamol, Chlormezanone, Prisinoform mesylate, Afloqualone, / kuclofen, Dantrolene sodium.
  • Procainamide hydrochloride disopyramide, azimaline, quinidine sulfate, apridine hydrochloride, propafenone hydrochloride, mexiletine hydrochloride. 1 7. Gout treatment
  • Ticlovidine hydrochloride dicoumarol, perfluoroaluminium.
  • Huetoin, sodium pulp oxalate, metal bital, carpa mazepine Huetoin, sodium pulp oxalate, metal bital, carpa mazepine.
  • Clonorefeniramine maleate clemastine fumarate, mequitazine, alimemazine tartrate, cycloheptadine hydrochloride.
  • Daribengramide tonolebutamide, glymidine sodium, troglitazone, oral ciglitazone, pioglitazone hydrochloride, epalrestat.
  • Vitamin B Interview Vitamin B 2, vitamin B 6, vitamin B Interview 2, vitamin C, ⁇ .
  • FIG. 1 is a side view showing a kneading extruder according to Embodiment 1 of the present invention.
  • FIG. 2 is a plan view of the kneading extruder shown in FIG.
  • FIG. 3 is an explanatory diagram of the kneading cylinder shown in FIG.
  • FIG. 4 is an explanatory diagram of the disk shown in FIG.
  • FIG. 5 is a longitudinal sectional view illustrating a movable mechanism that reciprocates the supply-side movable plate and the kneading-side movable plate illustrated in FIG.
  • FIG. 6 relates to Embodiment 2 of the present invention.
  • FIG. 1 is a plan view showing a kneading extruder.
  • FIG. 7 is a longitudinal sectional view illustrating the bearing shown in FIG.
  • FIG. 8 is a longitudinal sectional view illustrating a movable mechanism for reciprocating the mixing-side movable plate shown in FIG.
  • FIG. 9 shows the results of the dissolution test for Example 1.
  • the vertical axis represents the dissolution concentration of the drug ( ⁇ g Zml, the horizontal axis represents the test time (minutes).
  • X is the result of the drug substance powder
  • 100 is the result of the physical mixture
  • the results of the solid pharmaceutical dispersion according to Example 1 (the method of the present invention) are shown, and the results of the solid pharmaceutical dispersion according to Comparative Example 1 (solvent method) are shown as “ ⁇ ”.
  • the results of the dissolution test for Example 2 are shown, where the vertical axis represents the dissolved concentration of the drug ( ⁇ g Zml, and the horizontal axis represents the test time (minutes).
  • the results of the physical mixture one bite shows the result of the solid pharmaceutical dispersion according to Example 2 (the method of the present invention), and one plot shows the result of the solid pharmaceutical dispersion according to Comparative Example 2 (solvent method). Respectively.
  • FIG. 11 shows the results of the dissolution test for Example 3.
  • the vertical axis represents the dissolved concentration of the drug (g / ml), and the horizontal axis represents the test time (minutes).
  • X represents the results of the drug substance powder
  • — ⁇ represents the results of the physical mixture
  • ⁇ the results of the solid pharmaceutical dispersion according to Example 3 (the method of the present invention)
  • ⁇ the results of Comparative Example 3.
  • the results of the solid pharmaceutical dispersion according to (solvent method) are shown.
  • FIG. 12 shows the results of the dissolution test of Example 6.
  • the vertical axis represents the dissolved concentration of the drug (g / ml), and the horizontal axis represents the test time (minutes).
  • FIG. 13 shows the results of the dissolution test for Example 7.
  • the vertical axis indicates the dissolution concentration of the drug (tg / ml, the horizontal axis indicates the test time (minutes).
  • —X— indicates the result of the drug substance bulk, and bite— indicates the drug according to Example 7 (the method of the present invention).
  • the results for solid dispersions are 'represented respectively.
  • FIG. 14 shows the results of the dissolution test for Example 8.
  • the vertical axis represents the dissolved concentration ( ⁇ gZml) of the drug, and the horizontal axis represents the test time (minutes).
  • X represents the result of the drug substance,-represents the result of the physical mixture, and the bite represents the result of the solid pharmaceutical dispersion according to Example 8 (the method of the present invention).
  • FIG. 15 shows the results of the dissolution test for Example 9.
  • the vertical axis dissolve concentration of the pharmaceutical ( ⁇ ⁇ ⁇ 1), it represents a horizontal axis test time (min).
  • X represents the result of the drug substance powder, X represents the result of the physical mixture, and X represents the result of the solid pharmaceutical dispersion according to Example 9 (the method of the present invention).
  • FIG. 16 shows the result of X-ray diffraction analysis for Example 1.
  • the vertical axis represents the diffraction intensity (cps), and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the drug substance powder, the second chart from the top shows the results for the physical mixture, and the second chart from the bottom shows the results for the pharmaceutical solid dispersion according to Comparative Example 1 (solvent method).
  • the chart at the bottom shows the result of the solid pharmaceutical dispersion according to Example 1 (the method of the present invention).
  • FIG. 17 shows the result of X-ray diffraction analysis for Example 2.
  • the vertical axis represents the diffraction intensity (cps), and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the drug substance powder, the second chart from the top shows the results for the physical mixture, and the second chart from the bottom shows the results for the solid pharmaceutical dispersion of Comparative Example 2 (solvent method).
  • the bottom chart shows the results of the pharmaceutical solid dispersion according to Example 2 (the method of the present invention).
  • FIG. 18 shows the result of X-ray diffraction analysis for Example 3.
  • the vertical axis is the diffraction intensity
  • the top chart shows the results for the drug substance powder
  • the second chart from the top shows the results for the physical mixture
  • the second chart from the bottom The chart shows the results of the solid pharmaceutical dispersion according to Comparative Example 3 (solvent method)
  • the bottom chart shows the results of the solid pharmaceutical dispersion according to Example 3 (method of the present invention).
  • FIG. 19 shows the result of the X-ray diffraction analysis for Example 4.
  • the vertical axis represents the diffraction intensity (cps), and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the drug substance bulk, the middle chart shows the results for the physical mixture, and the bottom chart shows the results for the solid pharmaceutical dispersion according to Example 4 (the method of the present invention).
  • FIG. 20 shows the result of X-ray diffraction analysis on Example 5.
  • the vertical axis represents the diffraction intensity (cps), and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the drug substance powder, the middle chart shows the results for the physical mixture, and the bottom chart shows the results for the pharmaceutical solid dispersion according to Example 5 (the method of the present invention).
  • FIG. 21 shows the results of X-ray diffraction analysis for Examples 6 and 7.
  • the vertical axis represents the diffraction intensity (cps), and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the drug substance
  • the middle chart shows the results for the solid pharmaceutical dispersion according to Example 6 (the method of the present invention)
  • the bottom chart shows the results for the drug according to Example 7 (the method of the present invention).
  • the results of the solid dispersion are shown respectively. '
  • FIG. 22 shows the result of X-ray diffraction analysis for Example 8.
  • the vertical axis is the diffraction intensity
  • cps and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the bulk drug substance, the middle chart shows the results for the physical mixture, and the bottom chart shows the results for the solid pharmaceutical dispersion according to Example 8 (the method of the present invention).
  • ⁇ Figure 23 shows the result of X-ray diffraction analysis for Example 9.
  • the vertical axis represents the diffraction intensity (cps), and the horizontal axis represents the diffraction angle (°).
  • the top chart shows the results for the bulk drug substance, the middle chart shows the results for the physical mixture, and the bottom chart shows the results for the solid pharmaceutical dispersion according to Example 9 (the method of the present invention).
  • 1 kneading extruder (batch kneading extruder, intermittent kneading extruder), 2 material supply section, 3 discs, 4 material kneading section, 6 rotating shaft, 7 discharge port, 8 cylindrical side hole opening, 1 0 Kneading cylinder, 1 3 Supply cylinder, 1
  • the present invention generally relates to a method for preparing a kneaded material such as a predetermined amount of a pharmaceutically acceptable polymer carrier, a drug, and optionally other additives.
  • the mixture (simple mixture or physical mixture of the materials to be kneaded) is charged into the main kneading extruder, or the individual materials to be kneaded are simultaneously and quantitatively subjected to main kneading and extruding without a premix. It can be carried out by charging, shearing, kneading, extruding, etc., based on the function of the main kneading extruder to be used.
  • the compounding ratio of the polymer carrier and the drug to be used varies depending on the type of the polymer carrier and the drug used, the desired solid dispersion of the drug, etc., but does not differ from the compounding ratio in other production methods such as the solvent method. .
  • the compounding ratio in order to obtain a medically useful pharmaceutical solid dispersion in which the crystal peak of the drug has sufficiently disappeared by analyzing with an X-ray diffractometer, it depends on the drug used, the polymer carrier, other additives, etc.
  • at least 3 to L0 times the weight of the pharmaceutical agent is required for the drug in many cases.
  • additives may include compounds that overlap with each other, but include, for example, bulking agents, softeners, flow agents, lubricants, disintegrants, colorants, stabilizers, fragrances, solubilizers, and sorbents. , Antioxidants, pH regulators, surfactants, buffering agents, flavoring agents, desiccants, sweeteners, foaming agents, disintegration aids, preservatives, and cooling agents. These can be blended in appropriate amounts.
  • the bulking agent include milk bran, corn starch, crystalline cellulose, D-mannitol, sorbitol, xylitol, and calcium phosphate. The bulking agent is used in a solid dispersion.
  • the softener examples include water (tap water, distilled water, purified water, isotonic water such as physiological saline, neutral or acidic or basic buffer, 'or ammonia water, etc.), methanol, ethanol, isopro Solvents represented by alcohols such as panol and butanol, halogenated hydrocarbons such as chloroform, methylene chloride and trichloroethylene, hydrocarbons such as hexane, benzene and toluene, ethers and ketones; Bran alcohol such as erythritol, mannitol, xylitol, sorbitol, inositol, maltitol, arabitol, dulcitol; bran alcohol such as triethyl citrate, triacetin, propylene glycol, Spans and Tweens; In the dispersion, for example, it can be blended in the dispersion, for example, it can be blended in the dispersion, for
  • the fluidizing agent examples include long-chain fatty acids such as stearic acid; monoglycerides, diglycerides, and triglycerides of long-chain (C10-22) fatty acids; higher fats such as carnauba wax, polyoxyethylene hydrogenated castor oil, and stearyl alcohol. Wax such as alcohol and cetanol; lecithin and sodium lauryl sulfate; and the fluidizing agent can be blended in a solid dispersion, for example, within a range of 20% by weight or less.
  • Lubricants include, for example, light silicic anhydride, hydrous silicon dioxide, sodium stearyl fumarate, magnesium stearate, calcium stearate, synthetic aluminum chelate, magnesium metasilicate aluminate, dry aluminum hydroxide gel, talc
  • the lubricant may be incorporated in the solid dispersion, for example, in a range of 3% by weight or less.
  • disintegrant examples include low-substituted hydroxypropylcellulose, hydroxypropyl starch, carmellose, canolemellose sodium, croscanolemellose sodium, carmecium monocalcium, carboxymethyl starch sodium (Primodiel), Partially pregelatinized starch may be mentioned, and the disintegrant may be blended in a solid dispersion, for example, in a range of 20% by weight or less.
  • the colorant include iron sesquioxide, yellow iron sesquioxide, titanium oxide, and tar dyes. The colorant is blended in a solid dispersion, for example, in a range of 1% by weight or less. be able to.
  • a stabilizer for example, ascorbic acid or benzoic acid can be used, and the stabilizer can be blended in a solid dispersion, for example, within a range of 20% by weight or less.
  • fragrances include 1-menthol and orange extract. It can be blended within the range of weight ° / o or less.
  • the premix of the material to be kneaded can be prepared by a conventional method.
  • the material to be kneaded can be simplified by a machine such as an Ader mixer, a V-type mixer, a double cone mixer, a cubic mixer, or a ribbon mixer, or manually. Can be obtained by mixing them.
  • the premix of the material to be kneaded is charged into the main kneading extruder manually or by using a suitable material feeder, for example, a screw feeder, a staple feeder, a belt conveyor type constant feeder, or an electromagnetic feeder. Can be done.
  • a suitable material feeder for example, a screw feeder, a staple feeder, a belt conveyor type constant feeder, or an electromagnetic feeder.
  • these material feeders can be used not only for feeding the premix to the kneading extruder but also for simultaneously and quantitatively feeding the individual materials to be kneaded.
  • the processing temperature of the material to be kneaded depends on the type and blending ratio of the polymer carrier, medicine, and other additives used, the type of the main kneading extruder used (especially the shape characteristics of the rotating disk and the 'fixed disk') Although it depends on the speed, etc., it is desirable that the temperature of the material to be kneaded be higher than the glass transition temperature or higher than the softening temperature. Even at a temperature lower than the glass transition temperature or the softening temperature, a solid pharmaceutical dispersion may be produced depending on the type and blending ratio of the high molecular carrier and the pharmaceutical used. It is preferable that the material to be kneaded has reached at least near the processing temperature before reaching the rotating disk portion.
  • the temperature near the softening temperature of the material to be kneaded is maintained even before the material to be kneaded is extruded after passing through the rotating disk portion.
  • the processing speed (the number of rotations of the screw) depends on the type of the main kneading extruder used (especially the shape characteristics of the rotating disk and the fixed disk), the material to be kneaded, the processing temperature, etc. It can be set within the range. Specifically, 5 rpra or more is appropriate, and 10 to 30 Orpm is preferable.
  • the kneaded extrudate (pharmaceutical solid dispersion) extruded from the outlet can be cut to a desired length by an appropriate cutting machine, for example, a roller-type crusher, a cutter mill, a pin mill, or the like. This cut product can be used as it is or dried to obtain a granular pharmaceutical preparation.
  • the shape of the outlet is There is no particular limitation, and examples thereof include a polygon such as a circle, a triangle, a quadrangle, and a hexagon, and a star.
  • the appropriate diameter of the outlet is 0.5 to 5 thighs.
  • a capsule preparation can be made by packing the above-mentioned granules in a capsule or the like, and a tablet can be made by compression molding.
  • the capsules it is also possible to fill the capsules with the granules that have been subjected to a coating treatment or the like, or the granules or those that have been subjected to a coating process.
  • the strength of the pharmaceutical preparation can be further improved, and the stability of the pharmaceutical preparation can be enhanced.
  • Hydroxypropyl methylcellulose acetate succinate (HPMC A'S, trade name: AQ OAT, AS-LF grade, manufactured by Shin-Etsu Gigaku Kogyo Co., Ltd.) was added to 20 g of diphenedipine.
  • This pre-mixture is made of a 50 mm diameter, 20 mm wide disk (material: SACM645 nitrided) 3, and a 20 mm diameter, spiral screw 6a and screw type rotary shaft 6f.
  • H PMCP hydroxypropyl methylcellulose phthalate
  • HP-50F hydroxypropyl methylcellulose phthalate
  • a kneaded extrudate (pharmaceutical solid dispersion) was obtained by treating in the same manner as in Example 4 except that oxypeptinine hydrochloride was used as a drug and the motor speed was 30 rpm.
  • Example 6
  • a kneaded extrudate (pharmaceutical solid dispersion) was obtained in the same manner as in Example 5, except that indomethacin was used as the drug.
  • Example 1 Using a pre-mixture of 20 g of indomethacin and 100 g of a methacrylic acid copolymer (trade name: Eudragit L100-55, manufactured by Reem GmbH), the temperature of the supply-side cylinder 13 was set to 140 ° C, and the temperature of the kneading-side cylinder 10 was set.
  • the kneaded extrudate (pharmaceutical solid dispersion) was obtained in the same manner as in Example 1 except that the temperature was set to 150 ° C. and the number of rotations of the motor was set to 30 rpm.
  • Griseofulvin 20g Hydroxypropyl methylcellulose (HPM C, Trade name: TC-15R, Shin-Etsu Chemical Co., Ltd.) 160 g and erythritol 20 g were used as a pre-mixture, and the temperature of the supply cylinder 13 was 160 ° C and the temperature of the kneading cylinder 10 was A kneaded extrudate (pharmaceutical solid dispersion) was obtained in the same manner as in Example 1 except that the temperature was changed to 170 ° C.
  • HPM C Hydroxypropyl methylcellulose
  • TC-15R Shin-Etsu Chemical Co., Ltd.
  • a kneaded extrudate (pharmaceutical solid dispersion) was obtained in the same manner as in Example 8, except that phytoin was used as a pharmaceutical.
  • the kneaded extrudate (pharmaceutical solid dispersion) obtained in each example was finely pulverized by a sample mill, and the pulverized product obtained in each of the comparative examples and the solidified product (pharmaceutical solid dispersion)
  • the dissolution test was carried out on the pulverized material obtained by finely pulverizing the powdered product using a table-top small pulverizer. Examples:! The solubility of the drug substance according to Examples 1 to 3 and the solubility of the drug in the physical mixture of the drug substance and the polymer carrier according to Examples 1 to 3 in the same ratio are also the corresponding examples.
  • the test was performed under the same dissolution test conditions as in the test examples. Tables 1 and 2 show the conditions of the dissolution test. The results of each dissolution test are shown in Figs.
  • the solubility in the solid pharmaceutical dispersion obtained by the method of the present invention is much higher than the solubility in the drug substance powder or physical mixture, and It showed a solubility equal to or higher than that of a pharmaceutical solid dispersion obtained by a solvent method, which is one method for producing a solid dispersion.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)

Abstract

La présente invention concerne un procédé de production de médicament solide en dispersion, et notamment par compression et cisaillement de la matière à broyer par rotation d'un disque (3) puis par transfert spiral de la matière par rotation d'une vis spirale (6a) de façon à produire une matière broyée. En l'occurrence, pour produire un tel médicament solide en dispersion composé d'au moins un vecteur polymère pharmaceutiquement admis et d'un médicament, on utilise un broyeur-extrudeur (1). Cet appareil fait, par construction, que dans le synclinal entre un disque en rotation (3) et un disque fixe, la matière subit une extrusion centrifuge au niveau d'une zone limite des deux disques. Cette extrusion chasse alors la matière par l'interstice entre le pourtour du disque en rotation et la face interne du cylindre.
PCT/JP2003/003226 2002-03-19 2003-03-18 Procede de production de medicament solide en dispersion WO2003077827A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003575881A JPWO2003077827A1 (ja) 2002-03-19 2003-03-18 医薬固体分散体の製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002075541 2002-03-19
JP2002-75541 2002-03-19

Publications (1)

Publication Number Publication Date
WO2003077827A1 true WO2003077827A1 (fr) 2003-09-25

Family

ID=28035376

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/003226 WO2003077827A1 (fr) 2002-03-19 2003-03-18 Procede de production de medicament solide en dispersion

Country Status (2)

Country Link
JP (1) JPWO2003077827A1 (fr)
WO (1) WO2003077827A1 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005313608A (ja) * 2004-03-31 2005-11-10 National Institute Of Advanced Industrial & Technology 微量型高剪断成形加工機とそれを用いたナノ分散高分子ブレンド押出し物およびその製造方法
EP1832281A1 (fr) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Procédé pour la production d'une dispersion solide d'un ingredient actif
WO2008041553A1 (fr) 2006-09-26 2008-04-10 Astellas Pharma Inc. Préparation à libération entretenue de tacrolimus
JP2008515403A (ja) * 2004-09-30 2008-05-15 モノソル・アールエックス・エルエルシー 均一の成分を有する多層フィルム
WO2008084698A1 (fr) 2006-12-28 2008-07-17 Astellas Pharma Inc. Composition pharmaceutique à libération entretenue de tacrolimus
JP2010504789A (ja) * 2006-09-29 2010-02-18 インファ ソシエテ アノニム 薬学的組成物用調剤システム及び静脈内投与用キット
JP2011516612A (ja) * 2008-04-15 2011-05-26 シェーリング コーポレイション 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
EP2810660A1 (fr) 2013-06-03 2014-12-10 Shin-Etsu Chemical Co., Ltd. Composition destinée à l'extrusion à chaud et procédé de production d'un produit d'extrusion à chaud l'utilisant
EP2837391A1 (fr) 2013-08-12 2015-02-18 Shin-Etsu Chemical Co., Ltd. Succinate d'acétate d'hypromellose en tant que support d'extrusion à chaud, composition d'extrusion à chaud et procédé de production d'un extrudat thermofusible
JP2015536978A (ja) * 2012-11-07 2015-12-24 エスケー バイオファーマスティカルズ カンパニー リミテッド 難溶性薬物の固体分散体およびその製造方法
JP2017536401A (ja) * 2014-12-05 2017-12-07 アラゴン ファーマシューティカルズ，インコーポレイテッド 抗癌性組成物
CN109078186A (zh) * 2017-06-14 2018-12-25 江苏恒瑞医药股份有限公司 一种胃漂浮组合物及其制备方法
CN110314610A (zh) * 2019-08-02 2019-10-11 丁雷 一种适用于中药药丸自动生产设备
CN112656686A (zh) * 2020-12-19 2021-04-16 李灵芝 一种艾灸用艾柱制作加工工艺
US11224575B2 (en) 2014-12-05 2022-01-18 Aragon Pharmaceuticals, Inc. Anticancer compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505765A (ja) * 1991-02-11 1993-08-26 ゲルタイス，パウル 粒子状の材料を連続的に機械的に変形加工する方法および装置
EP0571778A1 (fr) * 1992-04-30 1993-12-01 Dow Corning Toray Silicone Company, Limited Procédé et appareil pour la préparation de mélanges de poudre
WO1995013794A1 (fr) * 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Procede pour produire une composition de medicament stable, et preparation pharmaceutique
WO2001089679A2 (fr) * 2000-05-22 2001-11-29 Warner-Lambert Company Production continue de granulation pharmaceutique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505765A (ja) * 1991-02-11 1993-08-26 ゲルタイス，パウル 粒子状の材料を連続的に機械的に変形加工する方法および装置
EP0571778A1 (fr) * 1992-04-30 1993-12-01 Dow Corning Toray Silicone Company, Limited Procédé et appareil pour la préparation de mélanges de poudre
WO1995013794A1 (fr) * 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Procede pour produire une composition de medicament stable, et preparation pharmaceutique
WO2001089679A2 (fr) * 2000-05-22 2001-11-29 Warner-Lambert Company Production continue de granulation pharmaceutique

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005313608A (ja) * 2004-03-31 2005-11-10 National Institute Of Advanced Industrial & Technology 微量型高剪断成形加工機とそれを用いたナノ分散高分子ブレンド押出し物およびその製造方法
JP2008515403A (ja) * 2004-09-30 2008-05-15 モノソル・アールエックス・エルエルシー 均一の成分を有する多層フィルム
JP2015038115A (ja) * 2006-03-10 2015-02-26 アボット ゲーエムベーハー ウント コンパニー カーゲー 活性成分の固体分散体を生産するための改良プロセス
EP1832281A1 (fr) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Procédé pour la production d'une dispersion solide d'un ingredient actif
WO2007104747A2 (fr) * 2006-03-10 2007-09-20 Abbott Gmbh & Co. Kg Procédé de production d'une dispersion solide d'un principe actif
JP2009529516A (ja) * 2006-03-10 2009-08-20 アボット ゲーエムベーハー ウント コンパニー カーゲー 活性成分の固体分散体を生産するためのプロセス
JP2009533320A (ja) * 2006-03-10 2009-09-17 アボット ゲーエムベーハー ウント コンパニー カーゲー 活性成分の固体分散体を生産するための改良プロセス
US9414992B2 (en) 2006-03-10 2016-08-16 Abbvie Deutschland Gmbh & Co Kg Process for producing a solid dispersion of an active ingredient
WO2007104747A3 (fr) * 2006-03-10 2007-11-29 Abbott Gmbh & Co Kg Procédé de production d'une dispersion solide d'un principe actif
US9205027B2 (en) 2006-03-10 2015-12-08 Abbvie Deutschland Gmbh & Co Kg Process for producing a solid dispersion of an active ingredient
WO2008041553A1 (fr) 2006-09-26 2008-04-10 Astellas Pharma Inc. Préparation à libération entretenue de tacrolimus
JP2010504789A (ja) * 2006-09-29 2010-02-18 インファ ソシエテ アノニム 薬学的組成物用調剤システム及び静脈内投与用キット
WO2008084698A1 (fr) 2006-12-28 2008-07-17 Astellas Pharma Inc. Composition pharmaceutique à libération entretenue de tacrolimus
JP2014139230A (ja) * 2008-04-15 2014-07-31 Merck Sharp & Dohme Corp 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
JP2011516612A (ja) * 2008-04-15 2011-05-26 シェーリング コーポレイション 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
JP2015536978A (ja) * 2012-11-07 2015-12-24 エスケー バイオファーマスティカルズ カンパニー リミテッド 難溶性薬物の固体分散体およびその製造方法
WO2014196519A1 (fr) 2013-06-03 2014-12-11 信越化学工業株式会社 Composition pour une extrusion par fusion thermique, et procédé pour produire un produit extrudé par fusion thermique l'utilisant
US10016508B2 (en) 2013-06-03 2018-07-10 Shin-Etsu Chemical Co., Ltd. Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same
EP2810660A1 (fr) 2013-06-03 2014-12-10 Shin-Etsu Chemical Co., Ltd. Composition destinée à l'extrusion à chaud et procédé de production d'un produit d'extrusion à chaud l'utilisant
US10646573B2 (en) 2013-06-03 2020-05-12 Shin-Etsu Chemical Co., Ltd. Composition for hot melt extrusion and method for producing hot melt extrudate by using same
EP2837391A1 (fr) 2013-08-12 2015-02-18 Shin-Etsu Chemical Co., Ltd. Succinate d'acétate d'hypromellose en tant que support d'extrusion à chaud, composition d'extrusion à chaud et procédé de production d'un extrudat thermofusible
US11090295B2 (en) 2013-08-12 2021-08-17 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate
JP2017536401A (ja) * 2014-12-05 2017-12-07 アラゴン ファーマシューティカルズ，インコーポレイテッド 抗癌性組成物
US11224575B2 (en) 2014-12-05 2022-01-18 Aragon Pharmaceuticals, Inc. Anticancer compositions
US11911511B2 (en) 2014-12-05 2024-02-27 Aragon Pharmaceuticals, Inc. Anticancer compositions
CN109078186A (zh) * 2017-06-14 2018-12-25 江苏恒瑞医药股份有限公司 一种胃漂浮组合物及其制备方法
CN109078186B (zh) * 2017-06-14 2021-09-03 江苏恒瑞医药股份有限公司 一种胃漂浮组合物及其制备方法
CN110314610A (zh) * 2019-08-02 2019-10-11 丁雷 一种适用于中药药丸自动生产设备
CN112656686A (zh) * 2020-12-19 2021-04-16 李灵芝 一种艾灸用艾柱制作加工工艺
CN112656686B (zh) * 2020-12-19 2022-11-22 山东艾乐语健康管理有限公司 一种艾灸用艾柱制作加工工艺

Also Published As

Publication number Publication date
JPWO2003077827A1 (ja) 2005-07-14

Similar Documents

Publication Publication Date Title
JP6932746B2 (ja) エンザルタミドの製剤
JP2527107B2 (ja) 固体分散体の製造方法
WO2003077827A1 (fr) Procede de production de medicament solide en dispersion
KR20110097829A (ko) 낮은 ｐＨ에서 불량한 수용해도를 갖는 이온화가능한 활성제의 제어 방출을 위한 고체 조성물, 및 그의 사용 방법
US20070148211A1 (en) Processes for making particle-based pharmaceutical formulations for oral administration
US20070231382A1 (en) Pharmaceutical composition
EA017290B1 (ru) Композиции на основе ганаксолона
NO336458B1 (no) Flerlags-doseringsformer inneholdende naproxen og triptaner, samt anvendelse av slike for behandling av hodepine
Nandy et al. An overview on fast dissolving drug delivery system
Shah et al. Melt extrusion in drug delivery: three decades of progress
WO2018108157A1 (fr) Composition pharmaceutique à libération prolongée / contrôlée de rucaparib pour la voie orale, et utilisation de cette dernière
NO173081B (no) Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen
JP2007314529A (ja) 造粒粒子、錠剤、及び造粒粒子の製造方法
AU2002331094A1 (en) Pharmaceutical composition comprising lumiracoxib
JP5835875B2 (ja) 口腔内速崩壊錠の製造方法
AU2002213900C1 (en) Pharmaceutical compositions
JP2022082720A (ja) 含量均一性を改善した製剤の製造方法
JP2013253093A (ja) ローラーコンパクターを使用した多微粒子の製造方法
US20060013871A1 (en) Intimate coating of ibuprofen with poloxamers to enhance aqueous dissolution
WO2002024168A1 (fr) Procede de production d'une dispersion solide medicinale
JP2004026750A (ja) 薬物の安定化法
JP5513936B2 (ja) 口腔内崩壊製剤
JP2012503020A (ja) 有機化合物のガレヌス製剤
JP2004024686A (ja) 医薬ワックスマトリックスの製法
CN111557914A (zh) 一种包含艾瑞昔布的药物组合物

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA CN JP KR RU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003575881

Country of ref document: JP

122 Ep: pct application non-entry in european phase